Metabolic Diseases  >>  Symlin (pramlintide)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
Closedloop, NCT01269008: Closed Loop System With Pramlintide Versus Exenatide

Completed
1
13
US
Medtronic ePID 2.0
Albert Einstein College of Medicine
Type 1 Diabetes
01/13
01/13
NCT01708044: Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Completed
1
32
US
Pramlintide acetate, Placebo
AstraZeneca, Juvenile Diabetes Research Foundation
Type 1 Diabetes
09/13
09/13

Download Options